Huntington’s risk spawns niche IVF market for people who don’t want a diagnosis

3-24-2019 in vitro x header
Image: Healthline

When Jennifer Leyton was going through IVF, her doctors would tell her very little. They turned off the ultrasound screen facing her… . They kept secret the number of fertilized embryos. … This secrecy might have been maddening for many IVF patients, but for Leyton, it was her choice.

She chose secrecy because she wanted to avoid finding out whether she had inherited a mutation for Huntington’s.

A genetic test that predicts almost perfectly whether someone will develop the disease has been available since the late 1980s, but only 8 percent of people at risk choose to test… . All someone at risk for Huntington’s might gain is certainty of how he or she will die. For this reason, a niche IVF market has sprung up for people like [Jennifer] Leyton who want no foresight of their own future but want to keep their children from ever worrying about the disease.

[IVF doctor Harvey] Stern says nondisclosure testing is ultimately about giving patients a choice not to know: “People have said, ‘How can you make people go through IVF when they do not need it?’ My answer has always been: ‘I’m not making anybody go through it.’”

Read full, original post: The Cost of Not Knowing a Huntington’s Diagnosis

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-06-17-at-12.31.01-PM
Viewpoint: The dangerous influence of ‘woke’ post-modernism in science
Screenshot-2026-06-26-at-10.14.50-AM
Viewpoint: The facts behind the grifter-promoting wellness and anti-aging peptide craze: Don’t waste your money
ChatGPT-Image-Jun-26-2026-01_21_33-PM
How the dubious, Trump-backed, addictive drug kratom could enrich cabinet secretary Markwayne Mullin
Screenshot-2026-06-25-at-11.18.03-AM
Viewpoint: Appreciating a simpler past without swallowing the misleading ‘nature is healthier and safer’ myth
ChatGPT-Image-Jun-26-2026-12_10_16-PM
Europe’s heat wave fueled recycled climate-denial narratives and harassment of climate scientists
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-06-25-at-1.48.40-PM
Glyphosate affirmed as safe: Supreme Court rejects lawsuit claiming Roundup herbicide causes cancer, upholding EPA determination
ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
ChatGPT-Image-Jun-26-2026-11_34_33-AM
Viewpoint: RFK, Jr.’s vaccine subterfuge campaign now flies below the media radar
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
ChatGPT-Image-Jun-23-2026-01_12_57-PM
After Mel Gibson’s Joe Rogan comments, grifters promoting ivermectin, without evidence, as a hantavirus preventive 
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.